This interactive webinar will discuss the latest developments and trends regarding natural opiates, semi-synthetic opioids, and synthetic opioids. Participants will be able to identify national and local NJ trends with regards to prescribing practices and new legislation, opioid overdoses and trends with opioid use. Participants will be able to distinguish the difference between which drugs are considered naturally occurring opiates, which are considered semi-synthetic opioids and which are considered synthetic opioids. Participants will be introduced into the assessment of and treatment of Opioid Use Disorders via the DSM 5 criteria, the latest nationally recognized medicated assisted treatment and the non-medication assisted treatment approaches when working with clients. Participants will be able to identify three different medicated assisted treatments (MAT), and discussion of medicinal marijuana being added as an MAT option. Webinar participants will be introduced to a harm reduction treatment paradigm and will be able to identify at least 3 different harm reduction principles when working with clients. Finally, participants will engage in an interactive case that will develop throughout the webinar and have different objectives (e.g., assessing a proper level of care, and then incorporating a harm reduction treatment orientation with the client in regards to their MAT decision process).

For more information and registration: Click here